R

Redhill Biopharma Ltd
D

RDHL

1.30000
USD
-0.06
(-4.41%)
مغلق
حجم التداول
0
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
2,983,949
أصول ذات صلة
A
AKRO
-0.205
(-0.44%)
46.710 USD
A
ALLO
-0.04500
(-3.81%)
1.13500 USD
D
DRRX
-0.02000
(-1.03%)
1.92500 USD
G
GNFT
-0.16000
(-3.77%)
4.08000 USD
I
IMUX
-0.04870
(-5.60%)
0.82130 USD
K
KALA
0.900
(8.51%)
11.470 USD
R
RCKT
-0.06000
(-1.80%)
3.28000 USD
S
SNGX
0.03000
(0.98%)
3.09000 USD
المزيد
الأخبار المقالات

العنوان: Redhill Biopharma Ltd

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-relatedproducts in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.